Evidence map›Paper›PMID 40432958›Full record

ArticleFrontiers in nutrition2025

Sustainable milk-based postbiotics beverages fermented by

Claudia Bellomo, Francesca Mauriello, Federica Nigro, Francesca Passannanti, Rosa Colucci Cante, Roberto Nigro, Maria Vittoria Barone, Merlin Nanayakkara

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Claudia BellomoDepartment of Translational Medical Science, Section of Pediatrics, University Federico II, Naples, Italy.
Francesca MaurielloDepartment of Chemical Engineering, Materials, and Industrial Production, University of Naples Federico II, Naples, Italy.
Federica NigroI.T.P. Innovation and Technology Provider S.r.l., Naples, Italy.
Francesca PassannantiDepartment of Chemical Engineering, Materials, and Industrial Production, University of Naples Federico II, Naples, Italy.
Rosa Colucci CanteDepartment of Chemical Engineering, Materials, and Industrial Production, University of Naples Federico II, Naples, Italy.
Roberto NigroDepartment of Chemical Engineering, Materials, and Industrial Production, University of Naples Federico II, Naples, Italy.
Maria Vittoria BaroneDepartment of Translational Medical Science, Section of Pediatrics, University Federico II, Naples, Italy.
Merlin NanayakkaraELFID (European Laboratory for the Investigation of Food Induced Diseases), University Federico II, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Celiac disease (CeD) is an autoimmune disorder characterized by damage to the small intestine that occurs in genetically predisposed individuals after gluten consumption. Dietary exclusion is the only treatment. Gliadin is one of the main protein component of wheat gluten, and is poorly digested. Undigested peptide, p31-43, triggers several different processes, including inflammation. Intestinal organoids from CeD biopsies are good models for studying CeD inflammation. Postbiotics have been shown to modulate the effects of p31-43 in Caco-2 cells and inflammation in CeD organoids. The aims of this study was to study the anti-inflammatory activity of milk-based postbiotics from of Methods: Postbiotics from Results: The results showed that pretreatment with all milk-based postbiotics of Conclusion: Milk-based postbiotics of

Indexed as

Caco-2 cellsceliac diseaseCLAinflammationintestinal organoidspostbiotic

Identifiers

PMID40432958
PMCPMC12107829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.